Rita Greco

Dr. Rita Greco

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
RGRita Greco
Rita Greco
VPVittorio Panetta
Vittorio Panetta
MRMaria Teresa Della Rocca
Maria Teresa Della Rocca
ADAdriana Durante
Adriana Durante
GCGiovanni Di Caprio
Giovanni Di Caprio
PMPaolo Maggi
Paolo Maggi
Bacterial co-infection in COVID-19 patients significantly contributes to the worsening of the prognosis based on morbidity and mortality. Information on the co-infection profile in such patients could help to optimize treatment. The purpose of this study was to describe bacterial co-infections associated with microbiological, clinical, and laboratory data to reduce or avoid a secondary infection. A retrospective cohort study was conducted at Sant’Anna and San Sebastiano Hospital from January 2020 to December 2021. Bacterial co-infection was detected in 14.3% of the COVID-19-positive patients. The laboratory findings on admission showed significant alterations in the median D-dimer, C-reactive protein, interleukin-6, and lactate dehydrogenase values compared to normal values. All inflammatory markers were significantly elevated. The most common pathogens isolated from blood cultures were E. faecalis and S. aureus. Instead, the high prevalence of respiratory tract infections in the COVID-19 patients was caused by P. aeruginosa (41%). In our study, 220 (82.4%) of the COVID-19 patients received antimicrobial treatment. Aminoglycosides and β-lactams/β-lactamase inhibitors showed the highest resistance rates. Our results showed that older age, underlying conditions, and abnormal laboratory parameters can be risk factors for co-infection in COVID-19 patients. The antibiotic susceptibility profile of bacterial pathogen infection provides evidence on the importance, for the clinicians, to rationalize and individualize antibiotic usage.

1 January 2023
Verified
Journal Article
Closed access
MRMaria Teresa Della Rocca
Maria Teresa Della Rocca
VPVittorio Panetta
Vittorio Panetta
ADAdriana Durante
Adriana Durante
LBLucio Bucci
Lucio Bucci
AMAlfredo Matano
Alfredo Matano
RGRita Greco
Rita Greco

11 March 2024 in Microbiologia Medica
Verified
Journal Article
Open access
PDF file
MRMaria Teresa Della Rocca
Maria Teresa Della Rocca
FMFilomena Merola
Filomena Merola
ADAdriana Durante
Adriana Durante
VPVittorio Panetta
Vittorio Panetta
SLStefano Labella
Stefano Labella
RGRita Greco
Rita Greco
This case report describes the identification of Ochrobactrum anthropi (O.a.), from a positive blood culture using MALDI-TOF spectrometry system. According to the information availed this is the first case in AORN Sant’Anna and San Sebastiano, Caserta, Campania, Italy. This microbe is moderately pathogenic and hazardous, with the potential to cause hospital-acquired infections. It is recommended that it be included in hospital “germ alerts”.

2 March 2026 in Microbiologia Medica
Verified
Journal Article
Open access
PDF file
TLTiziana Laurano
Tiziana Laurano
MRMaria Teresa Della Rocca
Maria Teresa Della Rocca
ADAdriana Durante
Adriana Durante
VPVittorio Panetta
Vittorio Panetta
MDMariassunta Claudia D'AMato
Mariassunta Claudia D'AMato
RGRita Greco
Rita Greco
Nocardia is a Gram-positive, weakly acid-fast bacterium that can cause nocardiosis, a serious infection that can lead to abscess formation in the central nervous system. In this report, we present a case of a primary brain abscess caused by Nocardia farcinica in an immunocompromised patient.